Metraipolis › archive › dc_2b839701e7ce

Pasireotide-LAR and pegvisomant combination in resistant acromegaly: a case series of predominantly mammosomatotroph adenomas — Europe PMC PMID:42778805

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42778805
DOI
10.1007/s11102-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-10-07T22:53:22.078Z
SHA-256 of the archived text
4d38f2ebe0f6eed2a0834d5abbf814f5283636ac6d356b9be425640515982217
Stable URL of this page
https://metraipolis.com/documento/dc_2b839701e7ce

How to cite

Pasireotide-LAR and pegvisomant combination in resistant acromegaly: a case series of predominantly mammosomatotroph adenomas — Europe PMC PMID:42778805 — Europe PMC (en), https://europepmc.org/article/MED/42778805 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b839701e7ce (Metraipolis archive dc_2b839701e7ce, sha256 4d38f2ebe0f6eed2a0834d5abbf814f5283636ac6d356b9be425640515982217)
BibTeX
@misc{dc2b839701e7ce,
  title = {Pasireotide-LAR and pegvisomant combination in resistant acromegaly: a case series of predominantly mammosomatotroph adenomas — Europe PMC PMID:42778805},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42778805},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b839701e7ce; sha256 4d38f2ebe0f6eed2a0834d5abbf814f5283636ac6d356b9be425640515982217},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42778805. Agents can read the archived copy with the MCP tool read_document.